METHODS Special Issue: Clinical and Analytical Performance Data for NxTAG RPP

Highly scalable, multiplex molecular assay is comparable to xTAG RVP performance If you’ve ever used an assay based on xTAG® Technology, you may wonder how the newer NxTAG® Chemistry stacks up. A new publication in Methods uses clinical and analytical data from respiratory pathogen panels to demonstrate how both performance and workflow have improved with [Read More…]

Multiplex Bead Mixes Made Easy with an Excel-Based Bead Calculator

Whether you’re developing a multiplex assay for 500 different markers in one reaction or developing lower-plex assays, knowing how to make a multiplex bead mix from different types of bead stocks is critical for proper assay performance. Unconjugated beads can be purchased as individual stocks at different concentrations of 12.5 or 2.5 million beads per [Read More…]

Bead-Based Multiplex Assay Shines in Performance Analysis

xMAP® Technology offers significant advantages in recent comparison to electrochemiluminescence platform. It’s clear why multiplex immunoassays play a prominent role in many modern laboratories. In addition to saving time, labor, and resources, multiplexing provides simultaneous quantification of multiple targets within small sample volumes. Different multiplex platforms have individual strengths, and in a recent study, scientists [Read More…]

How xMAP® Technology Advances Veterinary and Agricultural Research

New white paper reviews a host of recent studies based on xMAP® Technology When Luminex scientists first created xMAP® Technology back in the 1990s, they couldn’t possibly have imagined the vast array of applications for which it would eventually be utilized. We are continually impressed with our users’ creativity and scientific vision as they bring [Read More…]

Multiplexing Provides Richer Information for Veterinary Testing

Cornell scientists use Luminex® technology to skip long ELISAs and advance diagnostic test interpretation At Cornell University’s Animal Health Diagnostic Center (AHDC), scientists provide high-quality testing for a variety of animals while developing valuable new veterinary tests. Dr. Bettina Wagner, a veterinarian and immunology expert serving as the AHDC’s Director of Serology, has built several [Read More…]

For COVID-19 Detection and Epidemiology, xMAP® Technology Offers Unique Advantages

Multiplex serology tests have yielded impressive results, showing promise for use in the COVID-19 pandemic. xMAP-based serology tests have been widely implemented for the detection of pathogenic bacteria, viruses, and parasites. In the COVID-19 era, xMAP Technology has helped build several new multiplex serology tests designed to detect antibodies to different SARS-CoV-2 antigens. To demonstrate [Read More…]

How to Reduce Coupling Variability with Luminex Bead Assays

Top 10 tips for a successful coupling process If you’re designing a new multiplex bead-based assay or adding new targets to an existing xMAP® Technology-based assay, the coupling process required to add a protein or an antibody can seem daunting. We’re here to help! While the Luminex custom assay development service can help you with [Read More…]

xMAP® Technology Users Battle COVID-19 with New Serology Assays

Designed and built by researchers around the world, xMAP® assays shine light on the antibody response to SARS-CoV-2. Our xMAP® Technology empowers researchers to build their own assays quickly, creatively, and effectively. Designed and built by researchers around the world, xMAP® assays shine light on the antibody response to SARS-CoV-2. If you haven’t seen the [Read More…]

Webinar: Mouse Model Analysis Is Better with Multiplexing

Query hundreds of immunoassay targets, even with limited sample volume To make the most of immunology-focused assays using the limited tissue and fluid samples available from mouse models, scientists should consider using xMAP® Technology from Luminex, according to Daniel Braunschweig, Proteomics Field Application Scientist Leader at Bio-Rad Laboratories. That’s the takeaway from a 30-minute webinar [Read More…]

The Versatility of Multiplex Antibody Titer Assays for COVID-19 and Beyond

  The COVID-19 outbreak that began in Wuhan, China in December 2019 was marked by an increase in the number of cases showing pneumonia-like symptoms.1,2 It was not until about a month after the outbreak began that genomic analysis identified a novel coronavirus as the causative agent. With the emergence of new pathogen strains, genomic [Read More…]